United Therapeutics traded at $184.12 this Thursday May 19th, decreasing $1.27 or 0.68 percent since the previous trading session. Looking back, over the last four weeks, United Therapeutics lost 0.07 percent. Over the last 12 months, its price fell by 3.01 percent. Looking ahead, we forecast United Therapeutics to be priced at 178.40 by the end of this quarter and at 165.91 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Amarin 1.43 -0.04 -2.71% -68.71%
Ardelyx 0.67 0.01 1.23% -90.25%
Baxter International 72.58 0.46 0.64% -12.51%
Bayer 64.08 0.68 1.07% 14.45%
BioCryst Pharmaceuticals 8.63 0.11 1.23% -38.30%
Biogen 193.14 -2.57 -1.31% -32.60%
BioMarin Pharmaceutical 79.04 0.86 1.10% 3.43%
Emergent BioSolutions 32.14 3.80 13.41% -43.30%
Esperion Therapeutics 6.28 0.21 3.38% -69.36%
Gilead Sciences 63.33 0.11 0.17% -8.68%
GlaxoSmithKline 1,757.20 25.60 1.48% 29.68%
Halozyme Therapeutics 43.32 0.32 0.74% 2.97%
Intercept Pharmaceuticals 17.47 -0.41 -2.27% 2.80%
Insmed 19.73 -0.17 -0.85% -23.35%
Ionis Pharmaceuticals 37.95 -0.44 -1.15% 7.32%
Intra Cellular Therapies 59.21 0.71 1.21% 50.97%
J&J 174.24 -1.27 -0.72% 1.85%
Lexicon Pharmaceuticals 1.66 0.02 0.91% -61.95%
Moderna Inc 143.38 5.67 4.12% -13.61%
Omeros 2.87 -0.06 -2.05% -83.09%
Pfizer 50.67 0.27 0.54% 26.30%
PTC Therapeutics 31.73 0.22 0.70% -16.39%
Regeneron Pharmaceuticals 657.49 -1.72 -0.26% 28.11%
Seattle Genetics 144.35 1.35 0.95% -7.06%
Sangamo BioSciences 3.99 0.22 5.84% -63.53%
Sarepta Therapeutics 69.18 0.71 1.04% -10.06%
Teva Pharmaceutical Industries Ltd 2,779.00 -20.00 -0.71% -18.86%
United Therapeutics 184.12 -1.27 -0.68% -3.01%
Vertex Pharmaceuticals 255.51 3.16 1.25% 17.96%

Indexes Price Day Year
USND 11388 -29.66 -0.26% -15.86%
US400 2391 -4.34 -0.18% -10.89%

United Therapeutics
United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The Company market and sell four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution, which includes the Tyvaso Inhalation System; Orenitram (treprostinil) Extended-Release Tablets; and Adcirca (tadalafil) Tablets. In the United States, the Company also markets and sells an oncology product, Unituxin (dinutuximab) Injection, which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion.